Concurrent Disorder Management Guidelines. Systematic Review
Open accessThe DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders’ clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence-based strategies, including contingency management (CM), cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing (MI), acceptance and commitment therapy (ACT), and family-based interventions, have demonstrated their effectiveness in reducing substance use and enhancing treatment outcomes”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“The protocol for this systematic review was prepared according to the PRISMA-P checklist [25,26].”
MethodShamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · cited 1×
“In population-based studies, approximately one-fourth of people with anxiety or major depressive disorders are expected to have an overlapping substance use disorder in their lifetime [6,7].”
BackgroundRegier, D. A., Farmer, M. E., Rae, D. S., et al. (1990) · PubMed · Cited by 1,913
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 1×
“In population-based studies, approximately one-fourth of people with anxiety or major depressive disorders are expected to have an overlapping substance use disorder in their lifetime [6,7].”
BackgroundGalletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877 · cited 1×
“18 Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Management of Schizophrenia and Related Disorders [45] Royal Australian and New Zealand College of Psychiatrists New Zealand and Australia 2016 People with schizophrenia and related disorders”
BackgroundThe AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines
Brouwers, M. C., Kerkvliet, K., Spithoff, K., & AGREE Next Steps Consortium (2016) · BMJ · doi:10.1136/bmj.i1152 · Cited by 785
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Lynde, D., Osher, F. C., Clark, R. E., & Rickards, L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.469 · Cited by 693
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00073-2 · Cited by 617
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588 · cited 1×
“In mental health, the focus of research and guidelines has been on individual disorders, despite concurrent disorders being common and seemingly increasing [5].”
Background
Research works printed but not linked: 7
- Coexisting Severe Mental Illness (Psychosis) And Substance Misuse: Assessment and Management in Healthcare Settings. Clinical Guideline 2011 Available online: www.nice.org.uk/guidance/cg120 (accessed on 20 March 2020) 31851442
- Torres G.N. Dual Diagnosis: A Theoretical Approximation from Review of Literature J. Drug Abus. 2019 5 4 10.21767/2471-853X.100083 · doi:10.21767/2471-853x.100083
- Center for Substance Abuse Treatment Substance Abuse Treatment for Persons With Co-Occurring Disorders Treatment Improvement Protocol (TIP) Series 42 DHHS Publication No. (SMA) 05-3922 Substance Abuse and Mental Health Services Administration Rockville, MD, USA 2005 22514848
- Center for Substance Abuse Treatment Substance Abuse: Clinical Issues in Intensive Outpatient Treatment Treatment Improvement Protocol (TIP) Series 47. DHHS Publication No. (SMA) 06-4182 Substance Abuse and Mental Health Services Administration Rockville, MD, USA 2006 22514853
- Dennis C.D. Douathy A. Addiction and Mood Disorders-A Guide for Clients and Families Oxford University Press Oxford, UK 2006
- Bellack S.A. Bennett E. Gearon S.J. Behavioral Treatment for Substance Abuse in People with Serious and Persistent Mental Illness: A Handbook for Mental Health Professionals Routledge Abingdon, UK 2007 0-415-95283-2
- Noordsy D.L. Fox L. Drake E.R. Mueser T.K. Smith F.L. Integrated Treatment for Dual Diagnosis Disorders: A Guide to Effective Practice The Guilford Press New York, NY, USA 2003 1-57230-850-8
Cited by
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice
Martinotti, G., Chiappini, S., Mosca, A., Miuli, A., Santovito, M. C., Pettorruso, M., Skryabin, V. Y., Sensi, S. L., & Giannantonio, M. D. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220623092853 · Cited by 60
Glover‐Wright, C., Coupe, K., Campbell, A. C., Keen, C., Lawrence, P., Kinner, S. A., & Young, J. T. (2023) · Drug and Alcohol Review · doi:10.1111/dar.13651 · Cited by 46
“…outcomes for people with dual diagnosis, integrated models of mental health care and AOD specialist treatment have been developed and implemented [40] and most guidelines for the management of dual diagnosis recommend an integrated approach to mental health and AOD specialist treatment [41].”
BackgroundSpecial Issue: Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders)
Adán, A., & Torrens, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061307 · Cited by 37
Miguel, N., Marquez-Arrico, J. E., Jódar, M., Navarro, J. F., & Adán, A. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.06.006 · Cited by 38
Minkoff, K., & Covell, N. H. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000839 · Cited by 29
Ricci, V., Berardis, D. D., & Maina, G. (2024) · Healthcare · doi:10.3390/healthcare12030339 · Cited by 31
Harris, J., Dalkin, S. M., Jones, L., Ainscough, T., Maden, M., Bate, A., Copello, A. G., Gilchrist, G., Griffith, E., Mitcheson, L., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00104-9 · Cited by 26
Vita, A., Barlati, S., Cavallaro, R., Mucci, A., Riva, M. A., Rocca, P., Rossi, A., & Galderisi, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1451832 · Cited by 30
Jenkins, E., Currie, L. M., Hirani, S. S., Garrod, E., Goodyear, T., McGuinness, L., David, A., & Bonnie, K. (2022) · Nurse Education Today · doi:10.1016/j.nedt.2022.105483 · Cited by 28
Tang, V. M., Foll, B. L., Blumberger, D. M., & Voineskos, D. (2021) · Brain Sciences · doi:10.3390/brainsci12010048 · Cited by 16
Lavergne, M. R., Loyal, J. P., Shirmaleki, M., Kaoser, R., Nicholls, T. L., Schütz, C. G., Vaughan, A. D., Samji, H., Puyat, J. H., Kaulius, M., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07759-z · Cited by 18
Integrated nursing care for people with combined mental health and substance use disorders
Hove, E., Hazelton, M., Santangelo, P., & Wilson, R. L. (2022) · International Journal of Mental Health Nursing · doi:10.1111/inm.13094 · Cited by 26
Concurrent Disorders and Treatment Outcomes: A Meta-Analysis
Scott, K. D., & Gorey, K. M. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2515015 · Cited by 18
“Research has demonstrated that current treatment available for those with concurrent disorders are inadequate (Green et al., 2023; Hakobyan et al., 2020; Khan, 2017; Wiktorowicz et al., 2019).”
InfluentialPatel, H., Holshausen, K., Oshri, A., Andrews, K., Penta, S., Raymond, H., McKinnon, M., Brasch, J., MacKillop, J., & Amlung, M. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/07067437211011851 · Cited by 12
Leung, K., Xu, E., Rosic, T., Worster, A., Thabane, L., & Samaan, Z. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03489-4 · Cited by 13
Chicoine, G., Côté, J., Pépin, J., Boyer, L., Rouleau, G., & Jutras‐Aswad, D. (2022) · BMC Nursing · doi:10.1186/s12912-022-00943-w · Cited by 14
“Failure to address the complex healthcare needs of this subpopulation can lead to high relapse rates, long hospital stays and increased health care costs [4, 5].”
BackgroundKim, D. D., Procyshyn, R. M., Jones, A. A., Lee, L. H. N., Panenka, W. J., Stubbs, J. L., Cho, L. L., Leonova, O., Gicas, K. M., Thornton, A. E., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110795 · Cited by 9
Self-citationFoley, C., Allan, J., Lappin, J., Courtney, R. J., Farnbach, S., Aiken, A., & Shakeshaft, A. P. (2023) · Healthcare · doi:10.3390/healthcare11121786 · Cited by 9
Bertrand, E., & Morvillers, J. (2025) · Journal of Advanced Nursing · doi:10.1111/jan.16748 · Cited by 6
Düring, S. W., Sivertsen, D. M., & Johansen, K. S. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2478900 · Cited by 7
“…of guidelines and reviews have been published that provide an overview of the dual diagnosis field (Fantuzzi & Mezzina, 2020; Fisher et al., 2024; Hakobyan et al., 2020); however, Hakobyan et al. conclude that most guidelines rely on a limited evidence base for concurrent disorders, and…”
InfluentialRintoul, K., Song, E., McLellan-Carich, R., Schjelderup, E. N. R., & Barr, A. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1020038 · Cited by 5
Szerman, N., Parro-Torres, C., Vega, P., Basurte-Villamor, I., & Ruíz-Veguilla, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1427561 · Cited by 11
“Moreover, whether simultaneous or sequential, the occurrence of both disorders in one individual can affect the course and prognosis of each condition (29).”
BackgroundTodesco, S., Chao, T. W.-C., Schmid, L., Thiessen, K. A., & Schütz, C. G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.794014 · Cited by 6
“Model-based assays for cognitive factors underpinning symptoms and disorders may yield insights into concurrent disorders and potential treatments, especially since psychopathology beyond symptom count have been understudied in this population (12).”
BackgroundStakehold ZXSY: Disorder Deficit Familial Asynchrony and Syndrome Z
(2023) · Journal of Medical Clinical Case Reports · doi:10.47485/2767-5416.1032 · Cited by 7
The Spectrum of Psychiatric Comorbidity in Individuals With Inflammatory Bowel Disease
Cadogan, K., Marrie, R. A., Graff, L. A., El-Gabalawy, R. M., Enns, M. W., Bolton, J. M., Sareen, J., & Bernstein, C. N. (2025) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaf035 · Cited by 5
Samokhvalov, A. V. (2021) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000125 · Cited by 4
“While these models by definition require more resources to be invested in each patient’s care, a significant boost in clinical effectiveness results in integrated care systems being more costeffective than sequential or parallel treatments.(13)”
BackgroundSpencer, L., Alderson, H., Scott, S., Kaner, E., & Ling, J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20115967 · Cited by 8
Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations
Bahji, A., Crockford, D. N., Brasch, J. S., Schütz, C. G., Buckley, L., Danilewitz, M., Dubreucq, S., Mak, M. S. B., & George, T. P. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241231128 · Cited by 5
Marshall, T., Reeson, M., Loverock, A., Lewis, A. E., King, I., Ilyas, R., Dixon, C. C., Viste, D., Azer, B., Chow, E., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241300957 · Cited by 8
Benito, A., Jiménez‐Múrcia, S., Tirado-Muñoz, J., & Adán, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020730 · Cited by 3
“However, clinical guidelines, consensus statements, and reviews on DD treatment [13], based on a combination of expert opinion, clinical experience, and research evidence [14], generally devote disproportionately limited attention to psychological therapy than to pharmacological therapy.”
Anxiety sensitivity and cannabis use: A systematic review and conceptualization of research findings
Short, N. A., Weese, R., Pezza, M., & Bedard‐Gilligan, M. A. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104733 · Cited by 4
Integrated treatment of dual disorders in The Netherlands: a qualitative study of client experiences
van Wamel, A., Lempens, A. L. F., & Neven, A. K. (2021) · Advances in Dual Diagnosis · doi:10.1108/add-12-2020-0029 · Cited by 4
Szerman, N., Carlos, P., Pinet, C., Martínez-Raga, J., Basurte, I., & Sáiz, P. A. (2022) · Actas Españolas de Psiquiatría · Cited by 5
Nibbio, G., Calzavara‐Pinton, I., Barlati, S., Stanga, V., Bertoni, L., Necchini, N., Zardini, D., Lisoni, J., Deste, G., & Vita, A. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.023 · Cited by 6
“The same holds true for clinical factors that are not directly related to SSD, such as substance use, which may benefit form multidisciplinary targeted interventions (Alsuhaibani et al., 2021; Hakobyan et al., 2020; Large et al., 2014; Murthy et al., 2019; Wilson et al., 2018).”
Todesco, S., Chao, T. W.-C., Gorsuch, L., & Schütz, C. G. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241303407 · Cited by 4
REDD-PAC Cohort Description: Researching Dual Diagnosis – Prognosis and Characteristics
Mårtensson, S., Johansen, K. S., Krarup, J., & Düring, S. W. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2022.2055250 · Cited by 4
“Despite the fact that integrated treatment has been recommended for several years, evidence for the method is still very sparse (Hakobyan et al., 2020; Hunt et al., 2014), given that this patient group is often excluded from clinical research on account of the inevitable difficulties in getting a…”
BackgroundMethodLuciani, K. R., Johal, P. K., Chao, T. W.-C., Thiessen, K. A., & Schütz, C. G. (2024) · American Journal on Addictions · doi:10.1111/ajad.13535 · Cited by 2
Skogseth, E. M., Strong-Jones, S., Brant, K., Quadri, O., & Jones, A. A. (2025) · Criminal Justice and Behavior · doi:10.1177/00938548251326174 · Cited by 3
“Studies often focus either on how people with SUDs can access SUD treatment or on how people with SMIs can access mental health treatment; the literature is largely mutually exclusive.”
InfluentialChiappini, S., Mosca, A., Miuli, A., d'Andrea, G., Cavallotto, C., Semeraro, F., Piro, T., Vicinelli, M. C., Tucci, R., Conidi, C., et al. (2025) · Psychopathology · doi:10.1159/000547322 · Cited by 4
Nsatimba, F., Sehularo, L. A., & Moagi, M. M. (2025) · BMC Nursing · doi:10.1186/s12912-025-04027-3 · Cited by 3
“Existing studies have primarily focused on treatment guidelines in general [17–20].”
Chicoine, G., Côté, J., Pépin, J., Pluye, P., & Jutras‐Aswad, D. (2023) · International Journal of Nursing Studies Advances · doi:10.1016/j.ijnsa.2023.100153 · Cited by 3
“In the field of mental health and addiction, the term “ concurrent disorders ” (also called dual diagnosis, co-occurring disorders, or comorbidity) refers to various combinations of substance use and mental health disorders in the same individual simultaneously (Hakobyan et al., 2020).”
BackgroundInfluentialDisorders due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_26 · Cited by 4
Yaqubi, H., May, T., & Burton, A. (2025) · Drug and Alcohol Review · doi:10.1111/dar.14013 · Cited by 2
“Co-located services that address both mental health and problematic alcohol consumption have been suggested as effective interventions in similar contexts [43, 44].”
Walter, Z. C., Quinn, C. A., Dingle, G. A., Pocuca, N., Baker, A., Beck, A. K., de Andrade, D., Toombs, M. R., & Hides, L. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045607 · Cited by 2
Rosic, T., Lovell, E., MacMillan, H. L., Samaan, Z., & Morgan, R. L. (2023) · The Canadian Journal of Psychiatry · doi:10.1177/07067437231212037 · Cited by 2
Wani, K. F., Rather, Y. H., Kousar, M. U., Roub, F., & Rasool, U. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176241257673 · Cited by 1
Gendy, M. N. S., Remers, S., Costello, M. J., Rush, B. R., & MacKillop, J. M. (2024) · PLOS mental health. · doi:10.1371/journal.pmen.0000074 · Cited by 1
Gendy, M. N. S., Remers, S., Samokhvalov, A. V., Sousa, S., Rush, B. R., Costello, M. J., & MacKillop, J. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2352604 · Cited by 1
“A recent systematic review evaluating concurrent disorders (CD) guidelines in the past 20 years suggested that appropriate matching of treatment needs and staging or grading of the pool patients are the main improvement aspects (Hakobyan et al., 2020).”
Carmichael, J. J., Ymer, L., & Ponsford, J. L. (2025) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2025.2487432 · Cited by 1
“…et al., 2010; Davies et al., 2024; Exner et al., 2022; Kuppelin et al., 2024; Sathananthan et al., 2022, 2024), the challenge of managing comorbidities remains a long-standing issue in psychiatric treatment and neuropsychological rehabilitation (Becker et al., 2014; Hakobyan et al., 2020).”
Sperry, S. H., & Lippard, E. (2025) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20240044 · Cited by 5
Vasiliu, O. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000582 · Cited by 1
Mihretu, A., Fekadu, A., Alemu, A. A., & Hanlon, C. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10840 · Cited by 1
“41 However, the current review found only one guideline from the Brazilian Association of Studies on Alcohol and Other Drugs (ABEAD) for the diagnosis and treatment of psychiatric comorbidity with alcohol and other substance dependence, which clearly described the scope and purpose of the guideline.”
InfluentialBenito, A., Jiménez‐Múrcia, S., Tirado-Muñoz, J., & Adán, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031105 · Cited by 1
Overington, L., Suschinsky, K. D., Bell, S., Pallikaras, V., Moran, C., Willows, M., & Corace, K. (2026) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000271 · Cited by 1
Sivertsen, D. M., Düring, S. W., Johansen, K. S., & Kirk, J. W. (2026) · Addiction Science & Clinical Practice · doi:10.1186/s13722-026-00681-3 · Cited by 1
“However, integrated treatment as an ‘umbrella term’ is the recommended best practice in dual diagnosis treatment [5, 11], with one of the most studied and evidence-based approaches being Integrated Dual Diagnosis Treatment (IDDT) [22].”
Aragón, M. L. V., López-Lorenzo, S., & Bulnes, N. J. (2021) · Revista Española de Drogodependencias · doi:10.54108/red.2021.46.03.001 · Cited by 1
Toledo-Lozano, C. G., Juárez, E. N. A., Tiburcio, M., del Río, A. Á., & Vargas-Huicochea, I. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-021-00693-x · Cited by 1
“Furthermore, while there is support and encouragement for a unified approach to mental health and substance use for people with DD, it is also recognized that system integration is difficult and that there is an urgent need to improve DD care and treatment services (Hakobyan et al., 2020; Laker, 2006) based on the col…”
BackgroundNavigating Schizophrenia Treatment: Balancing Symptom Relief and Long-Term Needs
Barabássy, Á., Dombi, Z. B., Csehi, R., & Djuric, D. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005488 · Cited by 1
Dual diagnosis and their care pathways for help-seeking: A multicenter study from India
Ghosh, A., Mukherjee, D., Khanra, S., Prasad, S., Mahintamani, T., Basu, A., Padhy, S. K., Suthar, N., Somani, A., Arya, S., et al. (2024) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_79_24 · Cited by 2
“[38] In our study, the likelihood of seeking integrated DD treatment had an erratic pattern.”
St-Pierre, I., & St-Pierre, L. (2024) · Discover Health Systems · doi:10.1007/s44250-024-00167-6 · Cited by 2
“Heterogeneous and complex needs characterize individuals with dual disorders [7].”
Aragón, M. L. V., López-Lorenzo, S., & Bulnes, N. J. (2021) · Revista Española de Drogodependencias · doi:10.54108/red.2021.46.03.002
Tichler, B. (2021) · Psychology and Behavioral Sciences · doi:10.11648/j.pbs.20211006.17
“In addition, substance use often exasperates PTSD symptoms, further complicating treatment adherence and outcomes [4, 9, 14, 15, 20].”
InfluentialEstablishing a System of Care for Severe and Refractory Dual Disorder in the State of Hawai'i.
Busch, G., & Seo, J. Y. (2022) · PubMed · Cited by 1
Chicoine, G., Côté, J., Pépin, J., Pluye, P., & Jutras‐Aswad, D. (2023) · Research Square · doi:10.21203/rs.3.rs-2504874/v1
Substances Pathological of Use and Syndrome Z: Medicine D
Furlanetto, M. L. (2023) · Journal of Integrated Health · doi:10.51219/jih/furlanetto-m-l-jr/4 · Cited by 1
Luciani, K. R., Johal, P. K., Chao, T. W.-C., Thiessen, K. A., & Schütz, C. G. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4438309
Toombs, E., Lund, J. I., Kushnier, L., Stopa, A., Wendt, D. C., & Mushquash, C. J. (2023) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2023.2293943 · Cited by 1
Disorders Due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_26-1 · Cited by 1
Working with Substance Use in Bipolar Disorder
Sperry, S. H., Whomsley, S. R. C., Smith, J. L., Menkes, M. W., Murphy, V. A., & Richardson, T. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-63349-2_18
Detecting Comorbidity Using Machine Learning
Lacsamana, Y. M., Sheikh, Z., Viltres, C. S., Marouf, A. A., Sailunaz, K., & Alhajj, R. (2024) · Lecture notes in social networks · doi:10.1007/978-3-031-75204-9_4
Schütz, C. G., Nicholls, T. L., Schmid, L., Penner, S., Massey, M., Thiessen, K. A., Todesco, S., Rafizadeh, R., Cowie, K. D., Syan, S. K., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251315516 · Cited by 2
Ramasubbu, C., Poonia, S., Brady-Randle, E., Schütz, C. G., & Rafizadeh, R. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2478897
“Available evidence suggests that certain approaches effective in treating each individual disorder may not be as effective or may even be ineffective when applied to the co-occurring disorders (Hakobyan et al., 2020).”
Bahji, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00661-8
“The suggestion that non-specialist clinicians should deprescribe SSRIs without psychiatric oversight further raises concerns about fragmentation of care and the potential destabilization of patients who have benefited from long-term treatment [ 49–51].”
Mental Health: Depression, Post-Traumatic Stress Disorder, Substance Misuse and Stigma
Nyamayaro, P. C., Nhunzvi, C., Mwamuka, R., Mihretu, A., & Chibanda, D. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009052733.071
Evaluation of an inpatient psychiatric unit dual diagnosis “Inreach” model
Foster, G., Innes, S. I., McNamara, S., Sanders, B., Bortignon, S., Weston, A., Jordan, L., & Hope, J. (2025) · Advances in Dual Diagnosis · doi:10.1108/add-11-2024-0032
Nessbach, D., & Simpson, A. (2025) · International Journal of Mental Health Nursing · doi:10.1111/inm.70129 · Cited by 1
“Dual diagnosis (DD) is the presence of a co-occurring substance use problem and mental health condition (Hakobyan et al. 2020).”
Health service utilization and medical costs for in-hospital death at the end of life
Duan, S., Xie, L., Yu, H., Cui, J., Zhao, H., Ding, T., Li, H., Li, B., & Yang, J. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13791-6
Sorsa, M. A., Hammervold, U. E., Rimstad, S. L., Storm, M., & Sagvaag, H. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07621-6
Chicoine, G., Côté, J., Pépin, J., Boyer, L., Rouleau, G., & Jutras‐Aswad, D. (2022) · Figshare · doi:10.6084/m9.figshare.20226991
Lavergne, M. R., Loyal, J. P., Shirmaleki, M., Kaoser, R., Nicholls, T., Schütz, C. G., Vaughan, A., Samji, H., Puyat, J. H., Kaulius, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19581923
Chicoine, G., Côté, J., Pépin, J., Boyer, L., Rouleau, G., & Jutras‐Aswad, D. (2022) · Figshare · doi:10.6084/m9.figshare.20226988
Coles, A. R. L., Perry, J. K., Hiscock, B. B., Fawcett, J. M., Harris, N., & Fawcett, E. J. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2606019
“However, having a single, more severe mental health condition increases the risk of developing concurrent SUDs (Hakobyan et al., 2020).”
A Psiquiatria e a Medicina Baseada em Evidências
Ferraz, M. R. (2025) · Saúde Coletiva (Barueri) · doi:10.36489/saudecoletiva.2025v16i103p18300-18311
Le trouble concomitant selon une perspective syndémique : une étude de cas multiples
St-Pierre, I., & St-Pierre, L. (2025) · Drogues santé et société · doi:10.7202/1123906ar
Dual Diagnosis Treatment Approaches
Schochet, C. (2026) · Springer eBooks · doi:10.1007/978-3-031-57159-6_14-1
Stergiopoulos, V., Hamilton, A. S., Mor, J., Parada, H., Tanguay, R. L., Stoiljkovic, B., Barbeau, B., & St-Amant, O. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08034-9
“Indeed people with substance use and concurrent disorders are among the most underserved internationally [1, 10, 43].”
InfluentialCo-Occurring Model of Trauma and Substance Use: An Application of a Joint Latent Profile Framework
Llamas, J. D. (2026) · Sci · doi:10.3390/sci8040078
“Co-occurring disorders present many unique challenges and generally have a poorer prognosis compared to those with a single disorder [2,3].”
InfluentialLittle, Corace, K., Costello, J., Shantz, R. N., Caudarella, A., Esposti, A., Garner, G., Henderson, J. L., Keough, M. T., MacKillop, J. M., et al. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437261433758 · Cited by 1
Nsatimba, F., Sehularo, L. A., & Moagi, M. M. (2026) · BMC Nursing · doi:10.1186/s12912-026-04650-8
Concurrent (Dual) Disorder Management Guidelines: Systematic Review Update
Hakobyan, S., Allan, Z., Lee-Cheong, S., Adorjan, K., Falkai, P., & Schütz, C. G. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083123
“The protocol of the study has been uploaded to PROSPERO (http://www.crd.york.ac.uk/prospero (accessed on 18 June 2025); ID: CRD420251076197) [22].”
Self-citationCheung, I. W., Carter, M., Dogherty, E. J., Goodyear, T., & Russolillo, A. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14535-w
“Mental health and substance use treatment and care systems are frequently described as fragmented and siloed [14].”
Patients’ Experiences Regarding the Nursing Care of Dual Diagnosis: A Qualitative Study
Nsatimba, F., Sehularo, L. A., & Moagi, M. M. (2026) · The Open Public Health Journal · doi:10.2174/01187494451230260428051244
Halladay, J. E., Gendy, M. N. S., Little, Hira, V., Taisir, R., Rahman, L., Britton, E. M., Shantz, R. N., Levitt, E. E., Amlung, M. T., et al. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2670633
Chiappini, S., Ricci, V., Filippis, S. D., Quattrone, D., Martinotti, G., on behalf of the Dual Care Study Group, Besana, F., Cutuli, M., Rocca, F. D., Faveretto, E., et al. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2026.2686094
“…prevalence and severe consequences of dual diagnosis, treatment options remain limited in both efficacy and scope; indeed, currently available guidelines generally support combinations of treatments for individual disorders with a very small evidence base for dual disorders (Hakobyan et al., 2020).”
Ferrari, M., Pawliuk, N., Shah, J. L., Abdel‐Baki, A., Tibbo, P. G., Addington, D. E., Roy, M., Joober, R., MacDonald, K., & Iyer, S. N. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.06.005
Cowie, K. D., Weller, A., Griffin, M., Rubin-Kahana, D. S., Dixon, M., Ross, J., Amani, B., Dickens, S. E., Hawke, L. D., Henderson, J. L., et al. (2026) · Early Intervention in Psychiatry · doi:10.1111/eip.70235
“In this age group, substance use disorders (SUDs) confer substantial mortality and disability burden (Danpanichkul et al. 2025) in addition to frequently co-occurring with other psychiatric concerns, often referred to as concurrent disorders (CDs) (Hakobyan et al. 2020).”
Vieira, J. L., Antony, M. M., Milligan, K., Tabri, N., & Kim, H. S. A. (2026) · Journal of Behavioral Addictions · doi:10.1556/2006.2026.00064
“Increasing speci fi city within GAD and addictive behaviour research is particularly important given that concurrent disorders tend to be associated with greater severity and worse prognosis for each condition than either alone (Corace, Arès, Overington, & Kim, 2022; Hakobyan et al., 2020).”
A Systematic Review on the Effectiveness of Cognitive Behavioral Therapy in Substance Use Disorders
Gülsatar, E. C., & Balkır, F. (2026) · Addiction Science Reviews · doi:10.35365/asr.26.2.09
Metadata
- Authors
- Hakobyan, S., Vazirian, S., Lee-Cheong, S., Krausz, M., Honer, W. G., & Schutz, C. G.
- Affiliations
- University of British Columbia (CA)
- King's College London (GB)
- Department of Psychiatry, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada
- Corresponding author
- Hakobyan, Syune
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-07-28
- Volume
- 9
- Issue
- 8
- Pages
- 2406
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7463987
- OpenAlex
- W3046093029
- Cited by
- 99
- References
- 66
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 17 · 2023: 15 · 2022: 12 · 2021: 12
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of British Columbia
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- concurrent disorders, dual diagnosis, substance use disorders, mental illness, guideline quality assessment, AGREE II, NICE guidelines, integrated treatment model, treatment complexity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
